
News|Articles|September 30, 2026
Topical vs. Ingestible Skincare: Why the Future Is Both
This Q&A with Maypro's Lauren Clardy discusses the innovation areas—from scientific substantiation to delivery systems—set to define the future of skin and hair health.
Advertisement
Advertisement
Topical skincare is increasingly focusing on formulation science. In this Q&A, Maypro's Lauren Clardy, senior director of scientific affairs, discusses formulation challenges, ingredient innovation, and why the industry is shifting from subjective consumer testing toward rigorous, instrumentally measured skin-health endpoints in both topical and ingestible beauty products.
Related to this article

The proposal would reverse FDA’s position that N-acetyl-L-cysteine is excluded from the supplement definition and would replace the agency’s enforcement discretion policy if finalized.

A look at HMOs research, FDA oversight, and claims scrutiny as developments expand in the infant formula category.

The effort targets adulteration, inconsistent quality documentation, and trade barriers, with a pilot that tests a shared quality protocol on real ingredient materials.

Forty-eight percent of respondents prioritized advice from qualified experts as a trust signal, while 50% trust AI tools, and 39% trust influencers for wellness advice.

Todd Harrison of Venable LLP says AB 2779 rightly removes supplements out of California’s food date rules, but brands still need stability data, contract manufacturer oversight, and federal uniformity.

Consumer interest is still strong in fiber, but a shift in perspectives is leading to innovative ways to meet changing health needs.
Advertisement
Advertisement


